Founded in 2013, MAE Group began by providing global regulatory affairs, clinical affairs, quality management, and program management services to medical device, in vitro diagnostic, bioscience and life science companies to commercialize products in target markets. MAE Group continues to provide these services to start-up and SME (Small and Medium Enterprises) as well as large blue-chip companies.
medical device and IVD start-up companies, from market research to initial product launch in target markets. MAE Group expertise lies with our in-depth knowledge of regulations and most importantly, interpretation and application of the requirements, to guide any company through the commercialization pathway to successful product launch with strategic and tactical alignment to business plans. MAE Group has established an excellent reputation with global regulatory bodies.
In 2021, MAE Group expanded the company’s vision leading the commercialization of a thermobrachytherapy oncology medical device, a platform technology, under the MAE Group brand.
MAE Group brings lifesaving medical devices to global markets.